Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Celik
Yusuf
Y
Celik
Fatma
F
D000818:Animals; D002908:Chronic Disease; D015536:Down-Regulation / Q000187:drug effects*; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism*; D006801:Humans; D039201:Integrin alpha3beta1 / Q000378:metabolism*; D007668:Kidney / Q000187:drug effects; D050199:Podocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D011692:Puromycin Aminonucleoside / Q000008:administration & dosage* / Q000494:pharmacology*; D051381:Rats
D039201:Integrin alpha3beta1; D011692:Puromycin Aminonucleoside